Gene · 7399
Papers2,630
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,630
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The analysis of cathepsin L that mediates cellular SARS-CoV-2 infection leading to COVID-19 in head and neck squamous cell carcinoma. | Front Immunol | 2023 | 37292206 | PubTator, text mining | PubMed |
| USH2A mutational spectrum causing syndromic and non-syndromic retinal dystrophies in a large cohort of Mexican patients. | Mol Vis | 2023 | 37287646 | PubTator, text mining | PubMed |
| Genetic causes of inherited retinal diseases among Israeli Jews of Ethiopian ancestry. | Mol Vis | 2023 | 37287645 | PubTator, text mining | PubMed |
| Functions of MAP3Ks in antiviral immunity. | Immunol Res | 2023 | 37286768 | PubTator, text mining | PubMed |
| DECIPHER: Improving Genetic Diagnosis Through Dynamic Integration of Genomic and Clinical Data. | Annu Rev Genomics Hum Genet | 2023 | 37285546 | PubTator, text mining | PubMed |
| Autophagy-related tumor subtypes associated with significant gene expression profiles and immune cell infiltration signatures to reveal the prognosis of non-small cell lung cancer. | J Cancer | 2023 | 37283800 | PubTator, text mining | PubMed |
| Comprehensive analyses of a CD8+ T cell infiltration related gene signature with regard to the prediction of prognosis and immunotherapy response in lung squamous cell carcinoma. | BMC Bioinformatics | 2023 | 37280525 | PubTator, text mining | PubMed |
| Development of cancer-associated fibroblast-related gene signature for predicting the survival and immunotherapy response in lung adenocarcinoma. | Aging (Albany NY) | 2023 | 37280069 | PubTator, text mining | PubMed |
| Natural killer cells- from innate cells to the discovery of adaptability. | Front Immunol | 2023 | 37275911 | PubTator, text mining | PubMed |
| Natural history of retinitis pigmentosa based on genotype, vitamin A/E supplementation, and an electroretinogram biomarker. | JCI Insight | 2023 | 37261916 | PubTator, text mining | PubMed |
| Innovative retargeted oncolytic herpesvirus against nectin4-positive cancers. | Front Mol Biosci | 2023 | 37251078 | PubTator, text mining | PubMed |
| Very Large Cystoid Macular Lesions Identified Using Outlier Analysis of Genetically Confirmed Inherited Retinal Disease Cases. | Ophthalmic Genet | 2023 | 37246744 | PubTator, text mining | PubMed |
| RNA-Seq Analysis Reveals an Essential Role of the cGMP-PKG-MAPK Pathways in Retinal Degeneration Caused by Cep250 Deficiency. | Int J Mol Sci | 2023 | 37240188 | PubTator, text mining | PubMed |
| Targeted adaptive long-read sequencing for discovery of complex phased variants in inherited retinal disease patients. | Sci Rep | 2023 | 37237007 | PubTator, text mining | PubMed |
| Case report: Compound heterozygous nonsense PCDH15 variant and a novel deep-intronic variant in a Chinese child with profound hearing loss. | Mol Genet Genomic Med | 2023 | 37232061 | PubTator, text mining | PubMed |
| Amelogenesis imperfecta: Next-generation sequencing sheds light on Witkop's classification. | Front Physiol | 2023 | 37228816 | PubTator, text mining | PubMed |
| Identification of novel variants in retinitis pigmentosa genes by whole-exome sequencing. | Rev Assoc Med Bras (1992) | 2023 | 37222315 | PubTator, text mining | PubMed |
| Nationwide genetic analysis of more than 600 families with inherited eye diseases in Argentina. | NPJ Genom Med | 2023 | 37217489 | PubTator, text mining | PubMed |
| A Novel Lymphangiogenesis-Related Gene Signature can Predict Prognosis and Immunosuppressive Microenvironment in Patients with Clear Cell Renal Cell Carcinoma. | Int J Med Sci | 2023 | 37213667 | PubTator, text mining | PubMed |
| Development of Novel Patient-Reported Outcome (PRO) and Observer-Reported Outcome (ObsRO) Instruments in Retinitis Pigmentosa (RP) and Leber Congenital Amaurosis (LCA): ViSIO-PRO and ViSIO-ObsRO. | Ophthalmol Ther | 2023 | 37210697 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7399/papers?page=18